AdamCastanoMDMS

Nuclear Cardiology, Non-Invasive Cardiology

Cardiologist, Cardiac Amyloid Specialist

Dr. Castano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2013 - 2017
Columbia University Mailman School of Public HealthMS, Statistics, 2014 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and Surgeons2010 - 2013
University of Michigan Medical SchoolClass of 2010
Princeton UniversityBA, Molecular Biology, Spanish Literature, 2001 - 2005

PubMed

26 citations
Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
David L. Narotsky, Adam Castano, Jonathan W. Weinsaft, Sabahat Bokhari, Mathew S. Maurer
The Canadian Journal of Cardiology. 2016-09-01
65 citations
TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis
Hannah Rosenblum, Adam Castano, Julissa Alvarez, Jeff Goldsmith, Stephen Helmke
Circulation. Heart Failure. 2018-04-01
1106 citations
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Julian D. Gillmore, Mathew S. Maurer, Rodney H. Falk, Giampaolo Merlini, Thibaud Damy
Circulation. 2016-06-14

Drug Reduces Hospitalization, Death from Progressive Form of Heart FailureAugust 27th, 2018
Resurrecting Tc 99m PYP: As Cardiac Amyloidosis Therapies Emerge, an Old Test Gains a New PurposeJuly 16th, 2018